カテゴリー： QYResearch, 世界

世界のCD抗原がん療法市場 2019年

【英語タイトル】Global CD Antigen Cancer Therapy Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X05230）・商品コード：DATA909X05230
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、CD抗原がん療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、モノクローナル抗体、抗体薬物複合体、三機能性および二重特異性T細胞エンゲージ抗体、その他、に、用途別には、病院、診療所、その他にセグメント区分し、CD抗原がん療法の世界市場を分析しました。


・エグゼクティブ・サマリー
・CD抗原がん療法の世界市場概要
・CD抗原がん療法の製造コスト構成分析
・CD抗原がん療法の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・CD抗原がん療法の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・CD抗原がん療法のセグメント分析（種類別）
（モノクローナル抗体、抗体薬物複合体、三機能性および二重特異性T細胞エンゲージ抗体、その他、）
・CD抗原がん療法のセグメント分析（用途別）
（病院、診療所、その他）
・CD抗原がん療法の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（AryoGen Biopharma、Biocad、Biogen Idec、Celltrion、Genentech、Genmab、GLYCART Biotechnology、Hetero Drugs、mAbxience、MedImmune、Merck、Sandoz、UCB、）
・CD抗原がん療法の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global CD Antigen Cancer Therapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on CD Antigen Cancer Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall CD Antigen Cancer Therapy market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of CD Antigen Cancer Therapy in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their CD Antigen Cancer Therapy manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
AryoGen Biopharma
Biocad
Biogen Idec
Celltrion
Genentech
Genmab
GLYCART Biotechnology
Hetero Drugs
mAbxience
MedImmune
Merck
Sandoz
UCB

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Monoclonal Antibodies
Antibody-Drug-Conjugates
Tri-Functional and Bi-Specific T-Cell Engager Antibodies
Other

Segment by Application
Hospitals
Clinics
Other

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of CD Antigen Cancer Therapy
1.1 Definition of CD Antigen Cancer Therapy
1.2 CD Antigen Cancer Therapy Segment by Type
1.2.1 Global CD Antigen Cancer Therapy Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Monoclonal Antibodies
1.2.3 Antibody-Drug-Conjugates
1.2.4 Tri-Functional and Bi-Specific T-Cell Engager Antibodies
1.2.5 Other
1.3 CD Antigen Cancer Therapy Segment by Applications
1.3.1 Global CD Antigen Cancer Therapy Consumption Comparison by Applications (2014-2025)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global CD Antigen Cancer Therapy Overall Market
1.4.1 Global CD Antigen Cancer Therapy Revenue (2014-2025)
1.4.2 Global CD Antigen Cancer Therapy Production (2014-2025)
1.4.3 North America CD Antigen Cancer Therapy Status and Prospect (2014-2025)
1.4.4 Europe CD Antigen Cancer Therapy Status and Prospect (2014-2025)
1.4.5 China CD Antigen Cancer Therapy Status and Prospect (2014-2025)
1.4.6 Japan CD Antigen Cancer Therapy Status and Prospect (2014-2025)
1.4.7 Southeast Asia CD Antigen Cancer Therapy Status and Prospect (2014-2025)
1.4.8 India CD Antigen Cancer Therapy Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of CD Antigen Cancer Therapy
2.3 Manufacturing Process Analysis of CD Antigen Cancer Therapy
2.4 Industry Chain Structure of CD Antigen Cancer Therapy

3 Development and Manufacturing Plants Analysis of CD Antigen Cancer Therapy
3.1 Capacity and Commercial Production Date
3.2 Global CD Antigen Cancer Therapy Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of CD Antigen Cancer Therapy
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 CD Antigen Cancer Therapy Production and Capacity Analysis
4.2 CD Antigen Cancer Therapy Revenue Analysis
4.3 CD Antigen Cancer Therapy Price Analysis
4.4 Market Concentration Degree

5 CD Antigen Cancer Therapy Regional Market Analysis
5.1 CD Antigen Cancer Therapy Production by Regions
5.1.1 Global CD Antigen Cancer Therapy Production by Regions
5.1.2 Global CD Antigen Cancer Therapy Revenue by Regions
5.2 CD Antigen Cancer Therapy Consumption by Regions
5.3 North America CD Antigen Cancer Therapy Market Analysis
5.3.1 North America CD Antigen Cancer Therapy Production
5.3.2 North America CD Antigen Cancer Therapy Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America CD Antigen Cancer Therapy Import and Export
5.4 Europe CD Antigen Cancer Therapy Market Analysis
5.4.1 Europe CD Antigen Cancer Therapy Production
5.4.2 Europe CD Antigen Cancer Therapy Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe CD Antigen Cancer Therapy Import and Export
5.5 China CD Antigen Cancer Therapy Market Analysis
5.5.1 China CD Antigen Cancer Therapy Production
5.5.2 China CD Antigen Cancer Therapy Revenue
5.5.3 Key Manufacturers in China
5.5.4 China CD Antigen Cancer Therapy Import and Export
5.6 Japan CD Antigen Cancer Therapy Market Analysis
5.6.1 Japan CD Antigen Cancer Therapy Production
5.6.2 Japan CD Antigen Cancer Therapy Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan CD Antigen Cancer Therapy Import and Export
5.7 Southeast Asia CD Antigen Cancer Therapy Market Analysis
5.7.1 Southeast Asia CD Antigen Cancer Therapy Production
5.7.2 Southeast Asia CD Antigen Cancer Therapy Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia CD Antigen Cancer Therapy Import and Export
5.8 India CD Antigen Cancer Therapy Market Analysis
5.8.1 India CD Antigen Cancer Therapy Production
5.8.2 India CD Antigen Cancer Therapy Revenue
5.8.3 Key Manufacturers in India
5.8.4 India CD Antigen Cancer Therapy Import and Export

6 CD Antigen Cancer Therapy Segment Market Analysis (by Type)
6.1 Global CD Antigen Cancer Therapy Production by Type
6.2 Global CD Antigen Cancer Therapy Revenue by Type
6.3 CD Antigen Cancer Therapy Price by Type

7 CD Antigen Cancer Therapy Segment Market Analysis (by Application)
7.1 Global CD Antigen Cancer Therapy Consumption by Application
7.2 Global CD Antigen Cancer Therapy Consumption Market Share by Application (2014-2019)

8 CD Antigen Cancer Therapy Major Manufacturers Analysis
8.1 AryoGen Biopharma
8.1.1 AryoGen Biopharma CD Antigen Cancer Therapy Production Sites and Area Served
8.1.2 AryoGen Biopharma Product Introduction, Application and Specification
8.1.3 AryoGen Biopharma CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Biocad
8.2.1 Biocad CD Antigen Cancer Therapy Production Sites and Area Served
8.2.2 Biocad Product Introduction, Application and Specification
8.2.3 Biocad CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Biogen Idec
8.3.1 Biogen Idec CD Antigen Cancer Therapy Production Sites and Area Served
8.3.2 Biogen Idec Product Introduction, Application and Specification
8.3.3 Biogen Idec CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Celltrion
8.4.1 Celltrion CD Antigen Cancer Therapy Production Sites and Area Served
8.4.2 Celltrion Product Introduction, Application and Specification
8.4.3 Celltrion CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Genentech
8.5.1 Genentech CD Antigen Cancer Therapy Production Sites and Area Served
8.5.2 Genentech Product Introduction, Application and Specification
8.5.3 Genentech CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Genmab
8.6.1 Genmab CD Antigen Cancer Therapy Production Sites and Area Served
8.6.2 Genmab Product Introduction, Application and Specification
8.6.3 Genmab CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 GLYCART Biotechnology
8.7.1 GLYCART Biotechnology CD Antigen Cancer Therapy Production Sites and Area Served
8.7.2 GLYCART Biotechnology Product Introduction, Application and Specification
8.7.3 GLYCART Biotechnology CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Hetero Drugs
8.8.1 Hetero Drugs CD Antigen Cancer Therapy Production Sites and Area Served
8.8.2 Hetero Drugs Product Introduction, Application and Specification
8.8.3 Hetero Drugs CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 mAbxience
8.9.1 mAbxience CD Antigen Cancer Therapy Production Sites and Area Served
8.9.2 mAbxience Product Introduction, Application and Specification
8.9.3 mAbxience CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 MedImmune
8.10.1 MedImmune CD Antigen Cancer Therapy Production Sites and Area Served
8.10.2 MedImmune Product Introduction, Application and Specification
8.10.3 MedImmune CD Antigen Cancer Therapy Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Merck
8.12 Sandoz
8.13 UCB

9 Development Trend of Analysis of CD Antigen Cancer Therapy Market
9.1 Global CD Antigen Cancer Therapy Market Trend Analysis
9.1.1 Global CD Antigen Cancer Therapy Market Size (Volume and Value) Forecast 2019-2025
9.2 CD Antigen Cancer Therapy Regional Market Trend
9.2.1 North America CD Antigen Cancer Therapy Forecast 2019-2025
9.2.2 Europe CD Antigen Cancer Therapy Forecast 2019-2025
9.2.3 China CD Antigen Cancer Therapy Forecast 2019-2025
9.2.4 Japan CD Antigen Cancer Therapy Forecast 2019-2025
9.2.5 Southeast Asia CD Antigen Cancer Therapy Forecast 2019-2025
9.2.6 India CD Antigen Cancer Therapy Forecast 2019-2025
9.3 CD Antigen Cancer Therapy Market Trend (Product Type)
9.4 CD Antigen Cancer Therapy Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 CD Antigen Cancer Therapy Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of CD Antigen Cancer Therapy
Table Global CD Antigen Cancer Therapy Production (K Units) Growth Rate Comparison by Types (2014-2025)
Figure Global CD Antigen Cancer Therapy Production Market Share by Types in 2018
Figure Monoclonal Antibodies Product Picture
Figure Antibody-Drug-Conjugates Product Picture
Figure Tri-Functional and Bi-Specific T-Cell Engager Antibodies Product Picture
Figure Other Product Picture
Table Global CD Antigen Cancer Therapy Consumption (K Units) Comparison by Applications (2014-2025)
Figure Global CD Antigen Cancer Therapy Consumption Market Share by Applications in 2018
Figure Hospitals
Figure Clinics
Figure Other
Figure Global CD Antigen Cancer Therapy Revenue (Million USD) (2014-2025)
Figure Global CD Antigen Cancer Therapy Production (K Units) (2014-2025)
Figure North America CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Figure Europe CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Figure China CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Figure Japan CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Figure Southeast Asia CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Figure India CD Antigen Cancer Therapy Market Size (Million USD) (2014-2025)
Table CD Antigen Cancer Therapy Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of CD Antigen Cancer Therapy in 2018
Figure Manufacturing Process Analysis of CD Antigen Cancer Therapy
Figure Industry Chain Structure of CD Antigen Cancer Therapy
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global CD Antigen Cancer Therapy Manufacturing Plants Distribution
Table CD Antigen Cancer Therapy Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table CD Antigen Cancer Therapy Capacity (K Units) of Major Manufacturers (2014-2019)
Table CD Antigen Cancer Therapy Production (K Units) of Major Manufacturers (2014-2019)
Table CD Antigen Cancer Therapy Production Market Share of Major Manufacturers (2014-2019)
Figure CD Antigen Cancer Therapy Production Share by Manufacturers in 2018
Table CD Antigen Cancer Therapy Revenue (Million US$) of Major Manufacturers (2014-2019)
Table CD Antigen Cancer Therapy Revenue Market Share of Major Manufacturers (2014-2019)
Figure CD Antigen Cancer Therapy Revenue Share by Manufacturers in 2018
Table CD Antigen Cancer Therapy Average Price (USD/Unit) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global CD Antigen Cancer Therapy Production by Regions 2014-2019 (K Units)
Table Global CD Antigen Cancer Therapy Production Market Share by Regions 2014-2019
Figure Global CD Antigen Cancer Therapy Production Market Share by Regions in 2018
Table Global CD Antigen Cancer Therapy Revenue by Regions 2014-2019 (Million USD)
Table Global CD Antigen Cancer Therapy Revenue Market Share by Regions 2014-2019
Figure Global CD Antigen Cancer Therapy Revenue Market Share by Regions in 2018
Table Global CD Antigen Cancer Therapy Consumption by Regions 2014-2019 (K Units)
Table Global CD Antigen Cancer Therapy Consumption Market Share by Regions 2014-2019
Figure North America CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure North America CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table North America CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure Europe CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure Europe CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table Europe CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure China CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure China CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table China CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure Japan CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure Japan CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table Japan CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure Southeast Asia CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure Southeast Asia CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure India CD Antigen Cancer Therapy Production Growth Rate 2014-2019 (K Units)
Figure India CD Antigen Cancer Therapy Revenue Growth Rate 2014-2019 (Million USD)
Table India CD Antigen Cancer Therapy Production, Consumption Import and Export (K Units)
Figure Global Consumption CD Antigen Cancer Therapy Market Share by Application (2014-2019)
Figure Global Value (Consumption) CD Antigen Cancer Therapy Market Share by Application (2014-2019)
Table AryoGen Biopharma CD Antigen Cancer Therapy Production Sites and Area Served
Table AryoGen Biopharma CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table AryoGen Biopharma CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table AryoGen Biopharma CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table AryoGen Biopharma CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure AryoGen Biopharma CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table AryoGen Biopharma CD Antigen Cancer Therapy Main Business and Markets Served
Table Biocad CD Antigen Cancer Therapy Production Sites and Area Served
Table Biocad CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Biocad CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biocad CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Biocad CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Biocad CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Biocad CD Antigen Cancer Therapy Main Business and Markets Served
Table Biogen Idec CD Antigen Cancer Therapy Production Sites and Area Served
Table Biogen Idec CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Biogen Idec CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Biogen Idec CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Biogen Idec CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Biogen Idec CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Biogen Idec CD Antigen Cancer Therapy Main Business and Markets Served
Table Celltrion CD Antigen Cancer Therapy Production Sites and Area Served
Table Celltrion CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Celltrion CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Celltrion CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Celltrion CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Celltrion CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Celltrion CD Antigen Cancer Therapy Main Business and Markets Served
Table Genentech CD Antigen Cancer Therapy Production Sites and Area Served
Table Genentech CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Genentech CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Genentech CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Genentech CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Genentech CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Genentech CD Antigen Cancer Therapy Main Business and Markets Served
Table Genmab CD Antigen Cancer Therapy Production Sites and Area Served
Table Genmab CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Genmab CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Genmab CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Genmab CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Genmab CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Genmab CD Antigen Cancer Therapy Main Business and Markets Served
Table GLYCART Biotechnology CD Antigen Cancer Therapy Production Sites and Area Served
Table GLYCART Biotechnology CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table GLYCART Biotechnology CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table GLYCART Biotechnology CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table GLYCART Biotechnology CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure GLYCART Biotechnology CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table GLYCART Biotechnology CD Antigen Cancer Therapy Main Business and Markets Served
Table Hetero Drugs CD Antigen Cancer Therapy Production Sites and Area Served
Table Hetero Drugs CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table Hetero Drugs CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table Hetero Drugs CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table Hetero Drugs CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure Hetero Drugs CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table Hetero Drugs CD Antigen Cancer Therapy Main Business and Markets Served
Table mAbxience CD Antigen Cancer Therapy Production Sites and Area Served
Table mAbxience CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table mAbxience CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table mAbxience CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table mAbxience CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure mAbxience CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table mAbxience CD Antigen Cancer Therapy Main Business and Markets Served
Table MedImmune CD Antigen Cancer Therapy Production Sites and Area Served
Table MedImmune CD Antigen Cancer Therapy Product Introduction, Application and Specification
Table MedImmune CD Antigen Cancer Therapy Production (K Units), Revenue (Million USD), Ex-factory Price (USD/Unit) and Gross Margin (2014-2019)
Table MedImmune CD Antigen Cancer Therapy Production Growth Rate (2014-2019)
Table MedImmune CD Antigen Cancer Therapy Production Market Share (2014-2019)
Figure MedImmune CD Antigen Cancer Therapy Revenue Market Share (2014-2019)
Table MedImmune CD Antigen Cancer Therapy Main Business and Markets Served
Table Merck CD Antigen Cancer Therapy Production Sites and Area Served
Table Sandoz CD Antigen Cancer Therapy Production Sites and Area Served
Table UCB CD Antigen Cancer Therapy Production Sites and Area Served
Figure Global CD Antigen Cancer Therapy Production (K Units) Growth Rate Forecast 2019-2025
Figure Global CD Antigen Cancer Therapy Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global CD Antigen Cancer Therapy Sales Price (USD/Unit) Forecast 2019-2025
Figure North America CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure North America CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Europe CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure China CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Japan CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure Southeast Asia CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India CD Antigen Cancer Therapy Production Growth Rate Forecast 2019-2025 (K Units)
Figure India CD Antigen Cancer Therapy Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Units) of CD Antigen Cancer Therapy by Type (2019-2025)
Table Global Consumption (K Units) of CD Antigen Cancer Therapy by Application (2019-2025)
Table CD Antigen Cancer Therapy Distributors List
Table CD Antigen Cancer Therapy Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

AryoGen Biopharma、Biocad、Biogen Idec、Celltrion、Genentech、Genmab、GLYCART Biotechnology、Hetero Drugs、mAbxience、MedImmune、Merck、Sandoz、UCB、

★調査レポート[世界のCD抗原がん療法市場 2019年] (コード：DATA909X05230)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のCD抗原がん療法市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のがん幹細胞療法市場 2019年
    DATA909X04993 / QYResearch / 2019年11月15日 / ※本調査レポートは、がん幹細胞療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、自家幹細胞移植、同種幹細胞移植、同系幹細胞移植、その他に、用途別には、病院、診療所、医学研究機関、その他にセグメント区分し、がん幹細胞療法の世界市場を分析しました。 ・エグゼクティブ・サマリー ・がん幹細胞療法の世界市場概要 ・がん幹細胞療法の製造コスト構成分析 ・がん幹細胞療法の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・がん幹細胞療法の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・がん幹細胞療法のセグメント分析（種類別） （自家幹細胞移植、同種幹細胞移植、同系幹細胞移植、その他）...The global Cancer Stem Cell Therapy market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cancer Stem Cell Therapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cancer Stem Cell Therapy market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cancer Stem Cell Therapy in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のT細胞抗原Gp39市場 2019年
    DATA909X16231 / QYResearch / 2019年11月20日 / ※本調査レポートは、T細胞抗原Gp39の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ECI-006、B型肝炎ワクチン、INX-021、ISF-35、その他に、用途別には、移植片対宿主病、乳がん、膀胱がん、膵臓がん、その他にセグメント区分し、T細胞抗原Gp39の世界市場を分析しました。 ・エグゼクティブ・サマリー ・T細胞抗原Gp39の世界市場概要 ・T細胞抗原Gp39の製造コスト構成分析 ・T細胞抗原Gp39の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・T細胞抗原Gp39の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・T細胞抗原Gp39のセグメント分析（種類別） （ECI-006、B型肝炎ワクチン、INX-021、ISF-35、その他）...The global T Cell Antigen Gp39 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on T Cell Antigen Gp39 volume and value at global level, regional level and company level. From a global perspective, this report represents overall T Cell Antigen Gp39 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of T Cell Antigen Gp39 in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の前立腺特異抗原市場 2019年
    DATA909X13816 / QYResearch / 2019年11月20日 / ※本調査レポートは、前立腺特異抗原の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、G-115、INO-5150、ADXS-PSA、AEZS-120、その他に、用途別には、前立腺がん、転移ホルモン抵抗性前立腺がん、その他にセグメント区分し、前立腺特異抗原の世界市場を分析しました。 ・エグゼクティブ・サマリー ・前立腺特異抗原の世界市場概要 ・前立腺特異抗原の製造コスト構成分析 ・前立腺特異抗原の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・前立腺特異抗原の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・前立腺特異抗原のセグメント分析（種類別） （G-115、INO-5150、ADXS-PSA、AEZS-120、その他）...The global Prostate Specific Antigen market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Prostate Specific Antigen volume and value at global level, regional level and company level. From a global perspective, this report represents overall Prostate Specific Antigen market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Prostate Specific Antigen in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のB細胞成熟抗原（BCMA）標的療法市場 2019年
    DATA909X04452 / QYResearch / 2019年11月15日 / ※本調査レポートは、B細胞成熟抗原（BCMA）標的療法の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、二重特異性抗体、抗体薬物コンジュゲート、キメラ抗原受容体T細胞に、用途別には、肝臓がん、呼吸器がん、脳がん、その他にセグメント区分し、B細胞成熟抗原（BCMA）標的療法の世界市場を分析しました。 ・エグゼクティブ・サマリー ・B細胞成熟抗原（BCMA）標的療法の世界市場概要 ・B細胞成熟抗原（BCMA）標的療法の製造コスト構成分析 ・B細胞成熟抗原（BCMA）標的療法の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・B細胞成熟抗原（BCMA）標的療法の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・B細胞成熟抗原（BCMA）標的療法のセグメント分析（種類別） （二重特異性抗体、抗体薬物コンジュゲート、キメラ抗原受容体T細胞）...The global B-Cell Maturation Antigen(BCMA) Targeted Therapies market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on B-Cell Maturation Antigen(BCMA) Targeted Therapies volume and value at global level, regional level and company level. From a global perspective, this report represents overall B-Cell Maturation Antigen(BCMA) Targeted Therapies market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of B-Cell Maturation Antigen(BCMA) Targeted Therapies in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の細胞性腫瘍抗原p53市場 2019年
    DATA909X05261 / QYResearch / 2019年11月15日 / ※本調査レポートは、細胞性腫瘍抗原p53の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、COTI-2、D-12PGJ3、APR-246、ATRN-502、セネルセンナトリウム、MJ-05、MX-225、その他に、用途別には、卵巣がん、前立腺がん、脳がん、その他にセグメント区分し、細胞性腫瘍抗原p53の世界市場を分析しました。 ・エグゼクティブ・サマリー ・細胞性腫瘍抗原p53の世界市場概要 ・細胞性腫瘍抗原p53の製造コスト構成分析 ・細胞性腫瘍抗原p53の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・細胞性腫瘍抗原p53の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・細胞性腫瘍抗原p53のセグメント分析（種類別） （COTI-2、D-12PGJ3、APR-246、ATRN-502、セネルセンナトリウム、MJ-05、MX-225、その他）...The global Cellular Tumor Antigen p53 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cellular Tumor Antigen p53 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cellular Tumor Antigen p53 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Cellular Tumor Antigen p53 in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界の白血球表面抗原CD47市場 2019年
    DATA909X10504 / QYResearch / 2019年11月20日 / ※本調査レポートは、白血球表面抗原CD47の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、B-6H12、ALX-148、CC-90002、PSTx-23、その他に、用途別には、リンパ腫、卵巣癌、虚血再灌流障害、腎移植拒絶、その他にセグメント区分し、白血球表面抗原CD47の世界市場を分析しました。 ・エグゼクティブ・サマリー ・白血球表面抗原CD47の世界市場概要 ・白血球表面抗原CD47の製造コスト構成分析 ・白血球表面抗原CD47の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・白血球表面抗原CD47の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・白血球表面抗原CD47のセグメント分析（種類別） （B-6H12、ALX-148、CC-90002、PSTx-23、その他）...The global Leukocyte Surface Antigen CD47 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Leukocyte Surface Antigen CD47 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Leukocyte Surface Antigen CD47 market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Leukocyte Surface Antigen CD47 in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...

    • ◆H&Iグローバルリサーチのお客様（例）◆